Dean D D, Muniz O E, Berman I, Pita J C, Carreno M R, Woessner J F, Howell D S
J Clin Invest. 1985 Aug;76(2):716-22. doi: 10.1172/JCI112026.
In the transition from proliferation to hypertrophic cell zones in the growth plate, there is an increase in chondrocyte volume and a corresponding decrease in collagen content to accommodate the enlarging cells. It is postulated that collagenase accounts for this collagen loss. To test this hypothesis, tibial growth plates were obtained from normal rats, rachitic rats deficient in vitamin D and phosphate, and rats after 48 and 72 h of healing from rickets. Collagenase was quantitated by a pellet assay based on the release of solubilized collagen from the endogenous insoluble collagen in the tissue homogenates. A fourfold greater collagen release and a concomitant sixfold greater hypertrophic cell volume were measured in rachitic growth plates compared with normal age-matched controls. During healing of rickets, collagenase activity and hypertrophic cell volume returned almost to control levels. Rachitic growth plates were dissected into the juxtaepiphyseal 1/3 and the juxtametaphyseal 2/3. The latter portion contained greater than 95% of the hypertrophic cells and 86% of the collagenase. The collagen-degrading activity was extracted from this region and was shown to be a true collagenase by its production of typical A fragments of tropocollagen produced by collagenase action. The enzyme was activated by aminophenylmercuric acetate and trypsin and was inhibited by EDTA, 1,10-phenanthroline, and a tissue inhibitor of metalloproteinases from human articular cartilage. Inhibitors of aspartic, cysteine, and serine proteases had no effect. Micropuncture fluids aspirated from rachitic cartilage contained latent collagenase activity, indicating an extracellular localization. Negative tests for hemoglobin in the rachitic cartilage samples indicated that there was no contamination by capillaries and that this was not a source of collagenase. It is concluded that extracellular collagenase accounts for the loss of cartilage matrix in the hypertrophic zone, and that this process may be distinct from that of capillary invasion.
在生长板从增殖细胞区向肥大细胞区的转变过程中,软骨细胞体积增大,胶原蛋白含量相应减少,以适应细胞的增大。据推测,胶原酶是导致这种胶原蛋白损失的原因。为了验证这一假设,从正常大鼠、缺乏维生素D和磷酸盐的佝偻病大鼠以及佝偻病愈合48小时和72小时后的大鼠获取胫骨生长板。通过沉淀分析法对胶原酶进行定量,该方法基于从组织匀浆中的内源性不溶性胶原蛋白释放出可溶解的胶原蛋白。与年龄匹配的正常对照组相比,佝偻病生长板中的胶原蛋白释放量增加了四倍,同时肥大细胞体积相应增大了六倍。在佝偻病愈合过程中,胶原酶活性和肥大细胞体积几乎恢复到对照水平。将佝偻病生长板分为骨骺旁1/3和干骺端旁2/3两部分。后一部分含有超过95%的肥大细胞和86%的胶原酶。从该区域提取的胶原蛋白降解活性经证明是一种真正的胶原酶,因为它产生了胶原酶作用产生的典型原胶原蛋白A片段。该酶被乙酸氨基苯汞和胰蛋白酶激活,并被EDTA、1,10-菲咯啉以及人关节软骨中的金属蛋白酶组织抑制剂抑制。天冬氨酸、半胱氨酸和丝氨酸蛋白酶抑制剂没有作用。从佝偻病软骨中吸出的微穿刺液含有潜在的胶原酶活性,表明其定位于细胞外。佝偻病软骨样本中血红蛋白的阴性检测表明没有毛细血管污染,这不是胶原酶的来源。结论是细胞外胶原酶导致肥大区软骨基质的损失,并且这个过程可能与毛细血管侵入过程不同。